DUBLIN--(BUSINESS WIRE)--The "Artificial Insemination Market Analysis By Type (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination), By End-use, By Source Type, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global artificial insemination market is expected to reach USD 2.63 billion by 2025
Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment for infertility. According to WHO, around 10% of women in the world are struggling to get pregnant. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in infertility around the world.
The exact estimation of infertility statistics is challenging, however, WHO monitors its prevalence across the world. At present, 46% of the global population lives in countries having low levels of fertility. According to United Nations, the global rate of fertility is expected to decline to 2.4 by 2030 and 2.2 by 2050. In developing or underdeveloped nations, medical consultation regarding infertility and childlessness was not easily accessible. Hence, there was lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF.
Some of the key players in this market include Irvine Scientific; Rinovum Women's Health, LLC; TenderNeeds Fertility; Conceivex, Inc.; Hi-Tech Solutions; among others.
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Research Methodology
Chapter 3 Market Variables, Trends, & Scope
Chapter 4 Artificial Insemination: Type Estimates & Trend Analysis
Chapter 5 Artificial Insemination: End-use Estimates & Trend Analysis
Chapter 6 Artificial Insemination: Source Type Estimates & Trend Analysis
Chapter 7 Artificial Insemination: Regional Estimates & Trend Analysis
Chapter 8 Competitive Landscape
- Vitrolife AB
- Genea Limited
- Rinovum Women's Health LLC
- Pride Angel
- Hi-Tech Solutions
- Irvine Scientific
- Kitazato
- Rocket Medical PLC
For more information about this report visit https://www.researchandmarkets.com/research/w9htj5/artificial?w=4
